Moderna (MRNA) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 86.3% | 43.7% | -34.0% | -32.7% | -32.6% | -43.1% | ||
| Changes by years, y/y, % | +115pp | -43pp | -78pp | +1pp | +0pp | +2.3% | |||
Moderna. ROE, %
Moderna. ROE, changes, pp
Moderna (MRNA) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -33.3% | -30.9% | -33.4% | -32.6% | -43.1% | -43.1% | |
| Changes by years, y/y, % | +13pp | +19pp | -15pp | +0pp | -10pp | |||
| Changes by quarters, q/q, % | -1pp | +2pp | -3pp | +1pp | -10pp | |||